FDA Authorizes Second Booster Shot for People 50 and Older Will Examine Long-Term Strategy Soon
The FDA has authorized a second Covid booster shot for people 50 and older and those 12 and older that have weakened immune systems. The decision was mostly based on data from Israel that shows it could be lifesaving for those over 60 but has only marginal benefits for younger people. Carolyn Johnson, science reporter at The Washington Post, joins us for the latest and also how the FDA will soon meet to discuss the long-term booster strategy for the rest of the population.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
See omnystudio.com/listener for privacy information.